Tenet Healthcare raises full year guidance, beats Q2 estimates

Tenet Healthcare (NYSE:THC) saw its shares increase on Tuesday following an upward revision of its revenue and profit forecasts for 2025, alongside better-than-expected Q2 results.

The hospital operator adjusted its 2025 revenue projection to between $20.95 billion and $21.25 billion, surpassing the earlier estimate of $20.6 billion to $21 billion. Additionally, it raised its adjusted profit forecast to a range of $15.55 to $16.21 per share, compared to the previous guidance of $11.99 to $13.12.

In premarket trading, the company's stock rose by 5%.

For the second quarter, Tenet  reported a revenue of $5.27 billion, reflecting a 3.1% increase and exceeding analysts' expectations of $5.16 billion. The company also achieved adjusted earnings per share of $4.02, significantly higher than the analyst forecast of $2.88 per share.

"Our strong second quarter results continue to demonstrate our ability to achieve solid same-store revenue growth, operational excellence driven by core fundamentals, and strong free cash flow generation," Saum Sutaria, Chairman and CEO of Tenet, stated.

Furthermore, the board of directors approved a $1.5B increase to the existing share repurchase program.